COS-Mediated Crosstalk Between ILC3s and B Cells: ANT BIO PTE. LTD. Multiplex IHC Kits Illuminate Mucosal Immunity Mechanisms

I

Mucosal immunity serves as the frontline defense against pathogens, with intricate cellular interactions underlying its regulatory networks. Innate lymphoid cells 3 (ILC3s), a critical component of the innate immune system, share phenotypic similarities with T helper cells and play pivotal roles in mucosal homeostasis. However, the molecular mechanisms governing the crosstalk between ILC3s and other immune cells, particularly B cells, remain incompletely understood. A landmark study published in Cellular & Molecular Immunology (2023) shed light on this mystery, identifying inducible T-cell costimulator (ICOS) as a key mediator of ILC3-B cell interactions. Notably, the 4-color multiplex fluorescence IHC kit from ANT BIO PTE. LTD. (Catalog No.: abs50012) played an indispensable role in visualizing the colocalization of these cell populations, providing direct morphological evidence for the proposed interaction mechanisms.

1. Literature Information

Title: Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells

Journal: Cellular & Molecular Immunology (2023)

DOI: 10.1038/s41423-023-01041-w

Authors: Xinping Lv, Shan Zhu, Jing Wu, et al.

Core Reagents from ANT BIO PTE. LTD.: 4-Color Multiplex Fluorescence IHC Staining Kit (Mouse/Rabbit Universal Secondary Antibody, Catalog No.: abs50012, Absin product line)

Related Product Link: AntBio - Fueling Research, Feeding Discovery

2. Research Background

ILC3s are evolutionarily conserved innate immune cells that reside primarily at mucosal surfaces, contributing to barrier integrity, pathogen clearance, and tissue repair. These cells exhibit functional parallels to T helper cells but lack antigen-specific receptors, enabling rapid responses to microbial stimuli. Inducible T-cell costimulator (ICOS), a member of the CD28 superfamily, is well-characterized for its role in T-cell activation and T-B cell crosstalk within lymphoid tissues. However, the expression and functional significance of ICOS on ILC3s, as well as its involvement in ILC3-mediated interactions with the immune microenvironment, remained elusive prior to this study.

Given the critical role of mucosal immunity in immune homeostasis and disease pathogenesis, deciphering the ILC3-B cell interaction mechanisms holds great promise for developing novel therapeutic strategies for mucosal disorders. This research aimed to fill this knowledge gap by investigating the role of ICOS in regulating ILC3 activation and their crosstalk with B cells.

3. Research Methodology

The research team employed a comprehensive experimental approach, integrating molecular biology, immunology, and imaging techniques to systematically explore the ICOS-mediated ILC3-B cell interaction axis. Key methodologies included:

•         Cell Isolation and Characterization: Isolation of ILC3s and B cells from human tonsil tissues, followed by flow cytometry analysis to detect ICOS expression on ILC3s and their activation status.

•         Functional Assays: In vitro co-culture experiments of ILC3s and B cells to evaluate the effects of ICOS costimulation on ILC3 survival, proliferation, and cytokine production (IL-22, IL-17A, IFN-γ, TNF, GM-CSF).

•         Multiplex Fluorescence IHC Staining: Utilization of ANT BIO PTE. LTD.'s 4-color multiplex fluorescence IHC kit (abs50012) to stain tonsil tissue sections for markers including CD3, CD20, and RORγt. This enabled visualization of the spatial colocalization of ILC3s (RORγt+) and B cells (CD20+) in situ.

•         Signal Pathway Validation: Investigation of the synergistic effects of ICOS and CD40 signaling on ILC3-B cell interactions, and evaluation of the requirement of CD40 signaling for ILC3-induced T-cell-independent B-cell IgA and IgM secretion.

•        

4. Key Research Findings

Through systematic investigation, the research team uncovered the critical role of ICOS in mediating ILC3-B cell crosstalk and mucosal immune regulation. The key findings are summarized as follows:

4.1 ICOS Expression on ILC3s Correlates with Activation Status

The study demonstrated that ICOS is expressed on human ILC3s, and its expression level is closely associated with the activated state of ILC3s. This suggests that ICOS may serve as a functional marker for activated ILC3s in mucosal tissues.

4.2 ICOS Costimulation Enhances ILC3 Functional Activity

ICOS costimulation significantly promoted the survival and proliferation of ILC3s. Moreover, it enhanced the capacity of ILC3s to secrete multiple proinflammatory cytokines, including IL-22, IL-17A, IFN-γ, TNF, and GM-CSF. These cytokines play crucial roles in mucosal barrier defense and immune regulation.

4.3 Synergistic ICOS and CD40 Signaling Mediates ILC3-B Cell Crosstalk

B cells were found to promote ILC3 functions through the synergistic effects of ICOS and CD40 signaling. Conversely, ILC3s induced T-cell-independent B-cell secretion of IgA and IgM, a process that primarily required CD40 signaling. This reciprocal interaction highlights the coordinated role of these costimulatory molecules in mucosal immunity.

4.4 Multiplex IHC Validates ILC3-B Cell Colocalization in Tonsil Tissues

Using ANT BIO PTE. LTD.'s 4-color multiplex fluorescence IHC kit (abs50012), the research team confirmed the spatial colocalization of ILC3s (RORγt+) and B cells (CD20+) in human tonsil tissues. This in situ evidence directly supports the existence of physical interactions between these cell populations, providing a morphological basis for the functional crosstalk observed in vitro.

5. Product Empowerment: The Critical Role of ANT BIO PTE. LTD.'s Multiplex IHC Kit

The visualization of cellular colocalization is a key step in validating intercellular interactions, and ANT BIO PTE. LTD.'s 4-color multiplex fluorescence IHC kit (abs50012) provided reliable technical support for this critical validation, ensuring the credibility of the research conclusions.

5.1 Product Information and Experimental Application

5.2 Technical Value in Mucosal Immunity Research

Mucosal tissues such as tonsils have complex cellular compositions, making the in situ visualization of specific cell populations challenging. ANT BIO PTE. LTD.'s multiplex fluorescence IHC kit addressed this challenge by enabling the simultaneous detection of multiple cell markers, allowing researchers to accurately identify and localize ILC3s and B cells within the complex tissue microenvironment. This not only confirmed the physical proximity of these cells but also provided direct evidence for their functional interactions, laying a solid foundation for the elucidation of the molecular mechanisms underlying mucosal immunity.

6. Brand Mission

As a professional supplier of life science reagents, ANT BIO PTE. LTD. is dedicated to providing high-quality, reliable products and comprehensive solutions to empower global life science research. The company's three specialized sub-brands cover the full spectrum of research needs in the life science field: Absin focuses on general reagents and kits, Starter specializes in antibodies, and UA is dedicated to recombinant proteins. Our core mission is to bridge the gap between cutting-edge scientific research and practical applications, accelerate the pace of scientific discovery, and contribute to the advancement of human health and regenerative medicine.

7. Related Product List

8. Disclaimer

This article is AI-compiled and interpreted based on the original work in DOI: 10.1038/s41423-023-01041-w. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

9. Brand Promotion Copy

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.